Loading company…
NanoCarrier develops nanotechnology drug delivery systems aimed at improving cancer treatment and reducing side effects.
Founded in 1996 and based in Kashiwa, Japan, NanoCarrier develops advanced drug delivery systems, mainly for oncology. The company has raised a total of JPY 1,360.0 mn; its most recent round, in March 2008, coincided with its public listing, with Nomura Securities and Teikoku Pharma USA among the investors. In 2023 it reported revenue of JPY 1,496.4 mn and EBITDA of JPY -9,220.4 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in